Maroon Venture Fund

“It turns out that one reason for the low percentage of dollars going to companies with women CEOs and executives is that there are so few women VCs. . .[but] True Wealth’s attraction isn’t just its gender focus. . .Their investments not only return a high ROI, but with an environmental and health focus to the investments, they make a social impact.” – Forbes, 2017Gender Matters The future of savvy investing is gender diverse. Women-led, venture capital backed start-ups financially outperform their male counterparts, utilizing less capital for a greater return. Despite the history of outperformance, there is a big blind spot in the market, creating a fantastic investment opportunity. That’s where the common sense strategy of creating True Wealth comes in, with a mission to deliver superior returns to our investors, portfolio companies, and communities by investing in highly-scalable, women-led businesses that improve environmental and/or human health. Where We Invest True Wealth Ventures is focused on investing in more women leaders who have proven to financially outperform in high growth markets of environmental and human health where women are making the vast majority of purchase decisions We know that women are especially interested in making a positive impact, as both entrepreneurs and investors, and are proud to be selected for the ImpactAssets 50 2021 List, a global list of impact fund managers recognized for demonstrated potential to create positive impact across sectors and asset classes. Therefore, we exclusively invest in companies that are both women-led and whose core value proposition is improving environmental and/or human health. Environmental Health Consumers and investors – and especially women – demand more sustainably designed and manufactured products and solutions without a negative environmental impact during their useful life or end-of-life. This category includes, but is not limited to, solutions like: Sustainably-produced building materials and energy systems Sustainably produced home goods (furniture, fashion, care and food) Green packaging Clean mfg & supply chain technology Sustainable ag tech Human Health The focus here is more on “health care vs sick care” with evidence-based solutions that explicitly improve health. The explicit exceptions are life sciences or any solution requiring heavy FDA approval (e.g. pharma, biotech, implantable medical devices.) This category includes, but is not limited to, solutions like: Health tech Food-as-medicine Wellness products and solutions Femtech Silver tech Clinical decision support Public/community health Women-Led Companies with more women at the leadership helm enjoy significantly better financial results. Women excel in a variety of areas that are important to 21st century leadership skills – areas like cooperation, communication, taking initiative and driving for results. We look for companies with at least: One full-time female founder or C-suite executive With significant decision-making authority With significant equity ownership How We Invest We like to be the first institutional investors at an early stage (usually Series Seed) with first checks up to $1M, and we often take a board seat. We generally reserve over half of our investment capital for follow-on investments. We look for companies where the founders see an acquisition exit opportunity within 3-5 years at a valuation of $100 million or more. We have also taken the Diversity Pledge and are intentional about building a diverse team and inclusive culture throughout the True Wealth Ventures Fund and portfolio.

Our network of venture studios provides the rescue capital, expertise and support that startups need to thrive. Rescue Capital We collaborate with founders and investors to revitalize promising early-stage startups that have not yet reached their potential. We can deploy capital discreetly and within days - then incubate teams in our network of studios for hands-on support. New Venture Creation Our venture studio teams work alongside entrepreneurs and seasoned executives to prototype, validate, seed and launch startups addressing human and planetary needs in various industries. New venture concepts are created in-house and in partnership with universities, investors, and experts. What Makes Us Different Human + Planetary Health: We build and invest in companies that improve human and planetary health – because they’re inextricably linked. A majority of our investments are earthshots, not moonshots. Rescue Capital: We provide capital to good companies facing challenges raising seed and Series A funding in this difficult market. And we do it discreetly. Our team brings decades of venturesome turnaround experience to our portfolio. We co-create and execute winning strategies for long-term value. Collaborative Network: We are the first and only network of venture studios across the U.S. All of our studio teams and portfolio companies collaborate on everything from GTM to hiring and beyond. Patient Capital: Backed by a family office, we understand growth can take time. We can also bring in like-minded family offices and top-tier VCs for subsequent growth capital. Portfolio Ownership: We provide founding team with meaningful equity in both their business and in all studio portfolio companies. Founding teams often receive anti-dilution protection up to Series A funding. Opportunity Zones: Our studios are in economic opportunity zones near research universities and concentrations of talent. This creates tax benefits for founding teams working in our locations.

SCOR Ventures is the venture investment arm of SCOR Reinsurance, responsible for both investing in and creating partnerships with startups across the insurtech landscape. Since 2017 we have built a global portfolio across three theses: (1) investing in tech-driven underwriting companies (MGAs, carriers) and distributors, (2) software solutions that benefit SCOR and/or our clients, and (3) companies that help people live healthier lives. Our investment scope includes both investments and commercial (re)insurance relationships with startups. We predominantly invest at late Seed / Series A and are interested in a broad range of B2B and B2B2C solutions across MedTech, wellness, wearables, data platforms, and software / AI platforms. What we’re looking for We invest across three thesis areas: Thesis 1: we invest and partner in the ‘Insurers of the Future’: tech-driven underwriting companies (MGAs, carriers) that offer multiple points of digital and business model differentiation across P&C and L&H. We provide direct access to SCOR expertise and our global network to help portfolio companies scale and/or access (re)insurance capacity. With a proven track record of supporting innovative underwriting propositions across multiple lines of business, we understand product development, program structuring, underwriting, pricing and distribution and thus have the capabilities to optimise partnerships between insurtechs and business partners. We predominantly invest at late Seed / Series A. We are class of business agnostic and have partnered with companies across a broad variety of personal and specialty lines. Thesis 2: we invest and partner in software solutions that benefit SCOR and/or our clients. We provide a broad understanding of the interests and pain points of insurers across the world, and the potential to connect companies with insurers through SCOR’s client services initiatives. We predominantly invest later stage vs. Thesis 1 (typically Series A-B) but have occasional appetite for Seed. We prioritise companies: developing data, tools, and methods for obtaining, understanding, pricing and transferring large portfolios of pre-aggregated risks, high-value individual risks such as energy facilities and construction mega-projects, and MGA/coverholder business delivering economically valuable additional services offering a visible outcome which can be used to boost client management or reduce risks. Focus areas include front-end (e.g., underwriting & pricing) policy administration, modelling, risk analytics, and claims developing platforms where insurance has not previously been embedded / distributed, but where SCOR Ventures sees substantial opportunities to close the global protection gap – e.g., marketplaces, “super apps”, b2b fintech, employee benefits working to solve climate and ESG challenges to support the net zero transition and cut emissions for SCOR and SCOR clients. Focus areas include ESG reporting, climate risk analysis and data, carbon offsetting as a solution, circular economy, diversity, equity, and inclusion (DEI) tech, and supply chain transparency. We also see several opportunities in the green insurance product space including solar production or maintenance guarantees, wind input parametric products, solar physical asset damage, cat-bond / ILS and insuring carbon credit projects. Thesis 3: We invest at the intersection of health and technology and partner with companies that help people live healthier lives, deliver in-force or claims outcome improvements, develop new business or add to SCOR’s Knowledge Center capabilities, and assist our clients to transform their offerings. We predominantly invest at late Seed / Series A and are interested in a broad range of B2B and B2B2C solutions across MedTech, wellness, wearables, data platforms, and software / AI platforms. How we operateIntegrated in the wider SCOR business: Direct access to the entirety of SCOR’s capabilities brings unique added value to our portfolio companies. SCOR’s core business has experts in nearly every country, line of business, and functional area, while SCOR Partners bring a broad range of client services, marketing and product development expertise. Mandate: focused on key markets in North America, EMEA and LATAM, with selective deployment in APAC and Africa. Stage and ownership: We invest Seed to Series B. We typically seek greater than 5% ownership at first investment, which may include a board seat (we have led or co-led half of our investments to date). Our investment is intended to make SCOR a meaningful contributor but leave founders room to manage their cap table. We look for a long-term investment and / or commercial relationship but do not seek a fast exit or to ultimately acquire portfolio companies. Partnership approach: we are active supporters of the companies we work with, assisting with technical input, recruitment, capital optimisation and more. The material growth of many insurtech MGAs and carriers has led to increasing demand for (re)insurance capacity; SCOR is a transparent, long-term partner. Insurtechs in SaaS and services segments, meanwhile, have benefited from SCOR’s long-standing client relationships, while SCOR benefits from bringing knowledge, links, and expertise regarding services with genuine value to our clients. We bring value to our portfolio companies by connecting them with other partner companies, as well as with founders and distribution leads in our network. Why partner with SCOR VenturesWe believe in fewer, deeper relationships over the long term. We are flexible and collaborative in our approach, tailoring a solution to your specific needs, in partnership with other insurers, reinsurers, and investors involved in your company as appropriate. We underwrite most major lines of business and geographies globally. We have a global network including insurance licenses but not a competing retail insurance arm. Insurers are our clients, so working with us does not limit your options to associate with insurers. In selected circumstances, we can offer access to Lloyd’s or SCOR’s insurance licenses in the U.S., Europe, Asia, Brazil, South Africa, and other markets. We look to move quickly with direct access to decision makers, whilst leveraging resources and expertise to ensure our partners can build relationships with the appropriate parts of our organization.

Rebel One is an early stage fund and global investor network accelerating rebel founders for a better world. We aim to democratize access to investing while solving the world’s most systemic problems aligned with our zero goals - zero pollution, zero poverty and zero disease. Our goal is to accelerate startups by building the world's largest community of angels investing in founders working to solve some of the world's greatest challenges.

We invest to‍ keep people healthy. We invest in companies to drive the shift from traditional sickcare to modern healthcare. People are not destined to become sick as they age. We believe humans can live longer and make the best of all their years. That's why we invest in companies that keep people and our environment healthy. Today, 1 out of 2 people in the world live with a chronic disease. This tragic reality is also the source of more than 80% of all healthcare costs globally. We believe the world can do better. It’s time to break the order of things. We refuse to wait until people get sick to only then be treated. We want to help people maintain and nourish their most precious resources - physical and psychological health. We’re at the front lines of this transformation by investing in pioneering early-stage companies in the US and Europe. We want to build a healthcare system that cares when it matters most. We want people to savor the joyful simplicity of optimal functioning.

Positron Ventures helps and funds Europe-based scientist-entrepreneurs who are pursuing moonshots for (planetary) health. We invest in scientist-entrepreneurs working on a breakthrough in their field, across the natural sciences. We back teams from day one in their pursuit of solving a major global challenge. We do this with pre-seed investments and, wherever needed, support across all aspects of building a company. If you are looking for funding, check out our investment criteria and shopping list, and our view on when to engage. If you think there might be a match, contact us at startups@positron.vc. Scientists who have not yet spun out a company but are interested in doing so, please check our scientist resources.